Press Releases
Our team at Pharmafocuseurope.com believes that press releases are an important marketing tool for highlighting a client's corporate message and ensuring it reaches their target audience. The feature can be used to publish business agreements, annual reports, financial results, corporate performances, important announcements, and any other important information that needs to be communicated to the target audience. Pharma companies can also use it to launch new products and promote existing ones.
Abiogen Pharma Completes The Acquisition Of Effrx
Monday, May 29, 2023Abiogen Pharma SpA Italian leading company in the field of osteoarticular and bone metabolism diseases is pleased to announce the acquisition of a stake in EffRx Pharmaceuticals SA a Swiss company that develops and markets prescription drugs targete...
Clever Leaves Partners with SOMAÍ Pharmaceuticals and Sends First Commercial Shipments to Portugal
Friday, May 26, 2023Clever Leaves Holdings Inc NASDAQ CLVR CLVRW a global medicinal cannabis company announced today that it has entered into a fiveyear agreement with SOMA Pharmaceuticals to supply its operations in Portugal with EUGMP certified CBD extracts from Colom...
HanAll Biopharma and Daewoong Pharmaceutical Enter into Co-Development Agreement with NurrOn Pharmaceuticals to Develop Therapy for Parkinson’s Disease
Friday, May 26, 2023HanAll Biopharma Co Ltd KRX KS and Daewoong Pharmaceutical Co Ltd KRX KS announced that they have entered into a codevelopment agreement with NurrOn Pharmaceuticals Inc a Bostonbased preclinicalstage biopharma NurrOn is focused on the discovering an...
Almirall and the Centre for Genomic Regulation (CRG) collaborate to develop and characterize novel preclinical models for non-melanoma skin cancer
Friday, May 26, 2023Almirall SA ALM a global biopharmaceutical company focused on medical dermatology has entered into a research collaboration with the Centre for Genomic Regulation CRG an international biomedical research institute of excellence The partnership aims t...
Oxford BioTherapeutics and Boehringer Ingelheim Agree on 2 Year Extension to their Second Multi-Year Collaboration in Cancer Immunology
Friday, May 26, 2023Oxford BioTherapeutics Ltd OBT a clinical stage oncology company with a pipeline of immunooncology and antibodydrug conjugate ADCbased therapies today announced that it has extended its second multiyear collaboration with Boehringer Ingelheim for an...
Inventiva announces that its partner Sino Biopharm received IND approval from the NMPA to initiate clinical trial with lanifibranor in China
Friday, May 26, 2023Daix France Long Island City New York United States BeijingHong Kong China May Inventiva Euronext Paris and Nasdaq IVA a clinicalstage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of nonal...
Akebia Therapeutics Enters into License Agreement with Medice Arzneimittel Pütter GmbH&Co.KG for the Commercialization of Vafseo® for the Treatment of Anemia associated with CKD in Europe and Australia
Friday, May 26, 2023Akebia Therapeutics Inc Nasdaq AKBA a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease today announced an agreement with MEDICE Arzneimittel Ptter GmbHCoKG Medice The Health Family for Medice to mar...
Pyxis Oncology to Acquire Apexigen
Thursday, May 25, 2023Pyxis Oncology Inc Pyxis Oncology Nasdaq PYXS a clinicalstage company focused on developing nextgeneration therapeutics to target difficulttotreat cancers and Apexigen Inc Nasdaq APGN a clinicalstage biopharmaceutical company focused on discovering a...
Endo Announces Agreement with MAIA Pharmaceuticals to Distribute Bivalirudin Injection in Ready-to-Use Vials
Thursday, May 25, 2023Endo International plc OTC ENDPQ announced today that its subsidiary Endo Ventures Limited has executed an agreement with MAIA Pharmaceuticals Inc to distribute bivalirudin injection in a readytouse mg mL singleuse vial in the US Endo will commercia...
Alvotech and Advanz Pharma extend strategic partnership to commercialize five proposed biosimilars in Europe
Thursday, May 25, 2023Alvotech NASDAQ ALVO a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and Advanz Pharma a UK headquartered global pharmaceutical company with a strategic focus on specialty hospit...
